News

When a virus outbreak occurs, understanding its genetic make-up quickly can provide valuable insights into how the virus is spreading and changing. At the Genomics Core Facility, we support researchers with the genomic technologies and infrastructure needed to generate these insights – sometimes when time is of essence.

A new paper in Nature Genetics, co-authored by a researcher in the Population Genomics group at Erasmus MC, employs advanced molecular biology techniques and computational tools to identify key genetic drivers of six autoimmune diseases in a rare immune cell type.

Patients diagnosed with the same type and grade of diffuse glioma can experience remarkably different disease courses. Understanding the biology behind these differences is essential for improving prognosis and advancing more personalised treatment strategies.

Since January, the Genomics Core Facility at Erasmus MC has welcomed a new bioinformatician: Minouk Noordsij. With an interdisciplinary academic background, she is driven by the challenge of transforming complex genomic data into insights with real-world relevance.

At the Erasmus MC Genomics Core Facility, we are proud to contribute to the ambitious Genome of Europe initiative — a pan-European effort to build a comprehensive reference genome cohort representing the genetic diversity of European citizens. This project will lay the foundation for advancing personalised medicine and improving healthcare across Europe.

Good news for researchers in proteomics! Because we value scientific progress and aim to contribute to large-scale proteomics research, we collaborated with Olink to form a Reveal research consortium. Through this strategic collaboration, we successfully negotiated a reduced rate for the Olink Reveal panel.